Pfizer and Celldex Therapeutics (CLDX) Present Data on CDX-110 at ASCO
Tweet Send to a Friend
Pfizer (NYSE: PFE) and Celldex Therapeutics (NASDAQ: CLDX) announced the presentation of updated data from two clinical trials of CDX-110 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
